The effect of soy protein containing soy isoflavones on serum concentration of cell adhesion molecules: A systematic review and meta-analysis of randomized controlled trials

Background: Soy protein in combination with soy isoflavones might reduce the serum concentration of inflammatory mediators. In this study, we attempted to summarize the effect of soy protein combined with soy isoflavones on circulating E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vasc...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitra Hariri (Author), Hamid Reza Baradaran (Author), Ali Gholami (Author)
Format: Book
Published: Elsevier, 2021-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_62e6e9f7e9a1423e8f7eb7964d96d981
042 |a dc 
100 1 0 |a Mitra Hariri  |e author 
700 1 0 |a Hamid Reza Baradaran  |e author 
700 1 0 |a Ali Gholami  |e author 
245 0 0 |a The effect of soy protein containing soy isoflavones on serum concentration of cell adhesion molecules: A systematic review and meta-analysis of randomized controlled trials 
260 |b Elsevier,   |c 2021-09-01T00:00:00Z. 
500 |a 0965-2299 
500 |a 10.1016/j.ctim.2021.102764 
520 |a Background: Soy protein in combination with soy isoflavones might reduce the serum concentration of inflammatory mediators. In this study, we attempted to summarize the effect of soy protein combined with soy isoflavones on circulating E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in adults. Methods: Clinicaltrials.gov, Web of Science, Cochrane Library, PubMed, and Scopus were searched for English articles with no time limit regarding publication up to December 2020. Thereafter, the mean changes from baseline and their standard deviations (SDs) for both intervention and comparison groups were used to calculate the effect size. We used DerSimonian and Laird random-effects model if the heterogeneity test was statistically significant. Cochran's Q test and I-squared statistic were also used to calculate the statistical heterogeneity of the intervention effects. Results: Eight articles were found as eligible for this study. The treatment duration was between 6 and 24 weeks. Soy isoflavones dose was in a range of 30-112 mg/day and soy protein dose was in a range of 11.25-52 g/day. Overall, taking soy protein supplements containing soy isoflavones was not associated with changes in cell adhesion molecules, E-selectin, ICAM-1, or VCAM-1 (WMD = 0.65, 95 % CI: -2.58, 3.89; p = 0.692; WMD = 2.68, 95 % CI: -0.98, 6.34; p = 0.151; WMD = 2.66, 95 % CI: -6.28, 11.61; p = 0.559, respectively). Conclusion: The combination of soy protein and soy isoflavones was not significantly associated with changes in levels of E-selectin, ICAM-1, and VCAM-1. However, we need more studies with a large sample size and more participants with different age categories in this regard. 
546 |a EN 
690 |a Soy foods 
690 |a Isoflavones 
690 |a Intercellular adhesion molecule-1 
690 |a Vascular cell adhesion molecule-1 
690 |a E-selectin 
690 |a Other systems of medicine 
690 |a RZ201-999 
655 7 |a article  |2 local 
786 0 |n Complementary Therapies in Medicine, Vol 61, Iss , Pp 102764- (2021) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S0965229921001059 
787 0 |n https://doaj.org/toc/0965-2299 
856 4 1 |u https://doaj.org/article/62e6e9f7e9a1423e8f7eb7964d96d981  |z Connect to this object online.